Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor Tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction

BJU International

Volumn 112, Issue 2, 2013, Pages

  Megas, Georgios ^a   Papadopoulos, Georgios ^a   Stathouros, Georgios ^a   Moschonas, Dimitrios ^a   Gkialas, Ioannis ^a   Ntoumas, Konstantinos ^a  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

erectile dysfunction; penile prosthesis; phosphodoesterase type 5 inhibitors; radical prostatectomy

Indexed keywords

TADALAFIL;

ADULT; AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY; PENIS PROSTHESIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; SEXUAL SATISFACTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; CARBOLINES; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; ORGAN SPARING TREATMENTS; PATIENT SATISFACTION; PENILE IMPLANTATION; PENILE PROSTHESIS; PHOSPHODIESTERASE 5 INHIBITORS; PROSTATECTOMY; TREATMENT OUTCOME;

EID: 84879691630     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11561.x     Document Type: Article

References (34)

1. Litwin MS, Gore JL, Kwan L, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007; 109: 2239-2247
2. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-1261
3. Walsh PC,. Radical prostatectomy, preservation of sexual function, cancer control. The controversy. Urol Clin North Am 1987; 14: 663-673
4. Walsh PC, Lepor H, Eggleston JC,. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983; 4: 473-485
5. Stanford JL, Stephenson RA, Coyle LM, et al. Prostate cancer trends 1973-1995. Publication no. 99-4543. SEER Program, National Cancer Institute, Bethesda, MD 1999.
6. Greene KL, Cowan JE, Cooperberg MR, Meng MV, DuChane J, Carroll PR,. Who is the average patient presenting with prostate cancer? Urology 2005; 66: 76-82
7. Stephenson RA,. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am 2002; 29: 173-181
8. Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 1310-1319
9. Hugosson J, Aus G, Becker C, et al. Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden. BJU Int 2000; 85: 1078-1084
10. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-1328
11. Montague DK,. Penile prosthesis implantation for end-stage erectile dysfunction after radical prostatectomy. Rev Urol 2005; 7 (Suppl. 2): S51-57
12. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283: 354-360
13. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH,. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346-351
14. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A,. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830
15. Crowe H, Costello AJ,. Prostate cancer: perspectives on quality of life and impact of treatment on patients and their partners. Urol Nurs 2003; 23: 279-285
16. Zippe CD, Pahlajani G,. Penile rehabilitation following radical prostatectomy: role of early intervention and chronic therapy. Urol Clin North Am 2007; 34: 601-618
17. Talcott JA, Rieker P, Propert KJ, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997; 89: 1117-1123
18. Catalona WJ, Basler JW,. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993; 150: 905-907
19. Quinlan DM, Epstein JI, Carter BS, Walsh PC,. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991; 145: 998-1002
20. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT,. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000; 164: 1929-1934
21. Walsh PC, Marschke P, Ricker D, Burnett AL,. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. J Urol 2000; 55: 58-61
22. Fraiman MC, Lepor H, McCullough AR,. Changes in Penile Morphometrics in Men with Erectile Dysfunction after Nerve-Sparing Radical Retropubic Prostatectomy. Mol Urol 1999; 3: 109-115
23. Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158: 1408-1410
24. Gallo L, Perdona S, Autorino R, et al. Recovery of erection after pelvic urologic surgery: our experience. Int J Impot Res 2005; 17: 484-493
25. Padma-Nathan H, McCullough AR, Giuliano F, Toler SM, Wohlhuter C, Shpilsky AB,. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003; 169: 375-376
26. Lee DJ, Cheetham P, Badani KK,. Penile rehabilitation protocol after robot-assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency. BJU Int 2010; 105: 382-388
27. Mirone V, Imbimbo C, Rossi A, et al. Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy. Asian J Androl 2007; 12: 395-402
28. Montorsi F, Brock G, Lee J, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 54: 924-931
29. Hatzimouratidis K, Burnett AL, Hatzichristou D, McCullough AR, Montorsi F, Mulhall JP,. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur Urol 2009; 55: 334-347
30. Wilson SK, Delk JR, Salem EA, Cleves MA,. Long-term survival of inflatable penile prostheses: single surgical group experience with 2384 first-time implants spanning two decades. J Sex Med 2007; 4: 1074-1079
31. Carson CC 3rd,. Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol 2004; 171: 1611-1614
32. Montague DK, Angermeier KW,. Current status of penile prosthesis implantation. Curr Urol Rep 2000; 1: 291-296
33. Elliott S, Latini DM, Walker LM, Wassersug R, Robinson JW,. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. J Sex Med 2010; 7: 2996-3010
34. Garber BB, Marcus SM,. Does surgical approach affect the incidence of inflatable penile prosthesis infection? Urology 1998; 52: 291-293